LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has surpassed 1,000 early-stage platform subscribers as it continues to advance its mobile healthcare application ecosystem. The company is preparing applications for anticipated future availability through both the Apple App Store and Google Play Store, according to a press release.
The applications currently under development are intended to support telehealth, healthcare communication, patient engagement, provider coordination, emergency response, and AI-assisted healthcare support initiatives. These efforts are part of LataMed AI's broader digital healthcare infrastructure strategy focused on emerging markets, including Latin America, where access to healthcare coordination and digital tools may be limited.
Management stated that certain applications are being prepared for submission to Apple and Google platforms following continued development, internal testing, platform review processes, and applicable regulatory considerations. No assurance can be provided regarding the timing of any public release or availability, the company emphasized.
The milestone of surpassing 1,000 early-stage platform subscribers reflects continued early interest and engagement with the LataMed AI healthcare technology ecosystem, according to management. The company believes that continued onboarding activity and user engagement may provide valuable operational feedback as development progresses and additional platform functionality is evaluated and refined.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: 'We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives.'
The company's broader technology initiatives remain focused on scalable healthcare infrastructure solutions intended to support underserved and developing markets. LataMed AI is positioning itself to participate in the ongoing modernization and digital transformation of healthcare delivery systems across these regions through telehealth infrastructure development, AI-driven healthcare technologies, regulatory progression initiatives, strategic partnerships, and operational expansion efforts.
The impact of this announcement is significant for emerging markets where healthcare access is fragmented. If successfully deployed, LataMed AI's applications could bridge gaps in patient-provider communication, enable remote consultations, and improve emergency response coordination. The 1,000-subscriber milestone suggests early validation of the platform's value proposition, though the company remains in development stage with no guarantee of commercial success.
For more information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
